Clinical Trial Update: Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update assessing safety, pharmacokinetics and biodistribution of the radiotracer 18F-OP-801 in ALS, Parkinson's disease, Alzheimer's di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Amyotrophic Lateral Sclerosis
• Multiple Sclerosis
• Parkinson Disease

Drugs mentioned

• 18F-OP-801

Snippet

Sponsor: Ashvattha Therapeutics, Inc. | Conditions: Amyotrophic Lateral Sclerosis (ALS), Parkinson Disease (PD) | Phase 1, Phase 2 | Status: RECRUITING